1 - 25 of 33 results for author:"Browning J.L." in Literature citations
Results Customize
› Repeat search in UniProtKB (20)
| Follicular dendritic cells emerge from ubiquitous perivascular precursors. Krautler N.J., Kana V., Kranich J., Tian Y., Perera D., Lemm D., Schwarz P., Armulik A., Browning J.L., Tallquist M. et al. Cell 150:194-206(2012) · Mapped (39) |
| Regulation of T(H)2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells. Leon B., Ballesteros-Tato A., Browning J.L., Dunn R., Randall T.D., Lund F.E. Nat. Immunol. 13:681-690(2012) · Mapped (3) |
| Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjogren's syndrome. Fava R.A., Kennedy S.M., Wood S.G., Bolstad A.I., Bienkowska J., Papandile A., Kelly J.A., Mavragani C.P., Gatumu M., Skarstein K. et al. Arthritis Res. Ther. 13:R182-R182(2011) · Mapped (7) |
| LTBR-pathway in Sjogren's syndrome: CXCL13 levels and B-cell-enriched ectopic lymphoid aggregates in NOD mouse lacrimal glands are dependent on LTBR. Fava R.A., Browning J.L., Gatumu M., Skarstein K., Bolstad A.I. Adv. Exp. Med. Biol. 691:383-390(2011) · Mapped (4) |
| TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor. Bista P., Zeng W., Ryan S., Bailly V., Browning J.L., Lukashev M.E. J. Biol. Chem. 285:12971-12978(2010) · UniProtKB (1) · Mapped (6) |
| A lymphotoxin-driven pathway to hepatocellular carcinoma. Haybaeck J., Zeller N., Wolf M.J., Weber A., Wagner U., Kurrer M.O., Bremer J., Iezzi G., Graf R., Clavien P.A. et al. Cancer Cell 16:295-308(2009) · Mapped (53) |
| Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjogren's syndrome in salivary glands of non-obese diabetic mice. Gatumu M.K., Skarstein K., Papandile A., Browning J.L., Fava R.A., Bolstad A.I. Arthritis Res. Ther. 11:R24-R24(2009) · Mapped (2) |
| Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. Browning J.L., Allaire N., Ngam-Ek A., Notidis E., Hunt J., Perrin S., Fava R.A. Immunity 23:539-550(2005) · Mapped (11) |
| TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Shao Z., Browning J.L., Lee X., Scott M.L., Shulga-Morskaya S., Allaire N., Thill G., Levesque M., Sah D., McCoy J.M. et al. Neuron 45:353-359(2005) · Mapped (3) |
| Visualization of lymphotoxin-beta and lymphotoxin-beta receptor expression in mouse embryos. Browning J.L., French L.E. J. Immunol. 168:5079-5087(2002) · Mapped (7) |
| BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Thompson J.S., Bixler S.A., Qian F., Vora K., Scott M.L., Cachero T.G., Hession C., Schneider P., Sizing I.D., Mullen C. et al. |
| Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-alpha-deficient mice. Rennert P.D., Hochman P.S., Flavell R.A., Chaplin D.D., Jayaraman S., Browning J.L., Fu Y.X. J. Exp. Med. 193:1227-1238(2001) · Mapped (6) |
| A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. Rennert P., Schneider P., Cachero T.G., Thompson J., Trabach L., Hertig S., Holler N., Qian F., Mullen C., Strauch K. et al. J. Exp. Med. 192:1677-1684(2000) · Mapped (1) |
| A chemokine-driven positive feedback loop organizes lymphoid follicles. Ansel K.M., Ngo V.N., Hyman P.L., Luther S.A., Forster R., Sedgwick J.D., Browning J.L., Lipp M., Cyster J.G. Nature 406:309-314(2000) · Mapped (12) |
| Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., Tschopp J., Browning J.L. J. Exp. Med. 190:1697-1710(1999) · Mapped (6) |
| The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues. Wu Q., Wang Y., Wang J., Hedgeman E.O., Browning J.L., Fu Y.X. J. Exp. Med. 190:629-638(1999) · Mapped (17) |
| BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.-L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H. et al. J. Exp. Med. 189:1747-1756(1999) · UniProtKB (2) · Mapped (5) |
| Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. Ngo V.N., Korner H., Gunn M.D., Schmidt K.N., Riminton D.S., Cooper M.D., Browning J.L., Sedgwick J.D., Cyster J.G. J. Exp. Med. 189:403-412(1999) · Mapped (32) |
| Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Rennert P.D., James D., Mackay F., Browning J.L., Hochman P.S. Immunity 9:71-79(1998) · Mapped (10) |
| TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. Chicheportiche Y., Bourdon P.R., Xu H., Hsu Y.-M., Scott H., Hession C., Garcia I., Browning J.L. J. Biol. Chem. 272:32401-32410(1997) · UniProtKB (2) · Mapped (2) |
| Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes. Mackay F., Bourdon P.R., Griffiths D.A., Lawton P., Zafari M., Sizing I.D., Miatkowski K., Ngam-ek A., Benjamin C.D., Hession C. et al. J. Immunol. 159:3299-3310(1997) · Mapped (6) |
| Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. Browning J.L., Sizing I.D., Lawton P., Bourdon P.R., Rennert P.D., Majeau G.R., Ambrose C.M., Hession C., Miatkowski K., Griffiths D.A. et al. J. Immunol. 159:3288-3298(1997) · Mapped (6) |
| Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Koni P.A., Sacca R., Lawton P., Browning J.L., Ruddle N.H., Flavell R.A. Immunity 6:491-500(1997) · Mapped (6) |
| TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Bodmer J.-L., Burns K., Schneider P., Hofmann K., Steiner V., Thome M., Bornand T., Hahne M., Schroeter M., Wilson A. et al. Immunity 6:79-88(1997) · UniProtKB (1) |
| A lymphotoxin-beta-specific receptor. Crowe P.D., VanArsdale T.L., Walter B.N., Ware C.F., Hession C., Ehrenfels B., Browning J.L., Din W.S., Goodwin R.G., Smith C.A. |